FUAN PHARMACEUTICAL (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.18 CNY | +4.50% |
|
+15.47% | -4.57% |
| Apr. 25 | Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
| Apr. 24 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 2.42B 334M | Sales 2023 | 2.65B 366M | Capitalization | 5.21B 720M |
|---|---|---|---|---|---|
| Net income 2022 | 205M 28.31M | Net income 2023 | 232M 32.04M | EV / Sales 2022 | 1.77 x |
| Net Debt 2022 | 10.45M 1.44M | Net cash position 2023 | 104M 14.37M | EV / Sales 2023 | 1.93 x |
| P/E ratio 2022 |
21.2
x | P/E ratio 2023 |
23.1
x | Employees | 3,292 |
| Yield 2022 |
1.39% | Yield 2023 |
1.14% | Free-Float | 17.16% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.50% | ||
| 1 week | +15.47% | ||
| Current month | +9.42% | ||
| 1 month | +9.42% | ||
| 3 months | +8.85% | ||
| 6 months | -12.37% | ||
| Current year | -4.57% |
1 week
3.63
4.25
1 month
3.414.25
Current year
2.924.47
1 year
2.925.15
3 years
2.925.50
5 years
2.928.01
10 years
2.8713.66
| Managers | Title | Age | Since |
|---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 40 | 21-12-09 |
Xue Song Yu
DFI | Director of Finance/CFO | 55 | 09-09-18 |
Tian Xiang Wang
CHM | Chairman | 68 | 09-09-18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tian Xiang Wang
CHM | Chairman | 68 | 09-09-18 |
Qin Tang
BRD | Director/Board Member | 55 | 09-09-18 |
Zi Wei Guo
BRD | Director/Board Member | 54 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.04% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 4.18 | +4.50% | 68,655,970 |
| 24-04-29 | 4 | +2.04% | 40,051,030 |
| 24-04-26 | 3.92 | -2.49% | 65,020,660 |
| 24-04-25 | 4.02 | +8.06% | 111,279,900 |
| 24-04-24 | 3.72 | +1.64% | 15,435,200 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Fuan Pharmaceutical (Group) Co.,Ltd. is a China-based company principally engaged in the sales of Active Pharmaceutical Ingredients (APIs) and intermediates, preparations and pharmaceuticals. The Company's pharmaceutical products mainly include antibiotics, anti-tumor medicines, respiratory system medicines and specialty medicines. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-24
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -4.57% | 687M | |
| +21.15% | 43.67B | |
| +20.67% | 22.51B | |
| +14.56% | 14.6B | |
| +14.41% | 13.74B | |
| +42.64% | 11.91B | |
| -8.37% | 7.04B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.42B |
- Stock Market
- Equities
- 300194 Stock
